Αποτελέσματα Αναζήτησης
1 Φεβ 2011 · The guidelines discuss the management of a variety of clinical syndromes associated with MRSA disease, including skin and soft tissue infections (SSTI), bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system (CNS) infections.
2 Απρ 2023 · The selection of empiric antibiotic therapy for the treatment of MRSA infection depends on the type of disease, local S. aureus resistance patterns, availability of the drug, side effect profile, and individual patient profile.
1 Φεβ 2011 · For health care–associated MRSA (HA-MRSA) or CA-MRSA pneumonia, IV vancomycin (A-II) or linezolid 600 mg PO/IV twice daily (A-II) or clindamycin 600 mg PO/IV 3 times daily (B-III), if the strain is susceptible, is recommended for 7–21 days, depending on the extent of infection.
3 Φεβ 2021 · This guideline is intended to assist in the clinical care of patients with suspected or confirmed MRSA infection in the UK. The 2008 MRSA guideline addressed both prophylaxis and treatment of MRSA; however, prophylaxis has not been included in the current guideline.
3 Φεβ 2021 · These evidence-based guidelines are an updated version of those issued in 2008. They have been produced following a review of the published literature (2007-18) pertaining to the treatment of infections caused by MRSA.
Options for treating both β-hemolytic streptococci and community-associated MRSA include clindamycin alone, TMP/SMX or a tetra-cycline in combination with a beta-lactam antibiotic...
15 Αυγ 2011 · The Infectious Diseases Society of America (IDSA) has released its first evidence-based guidelines on the treatment of MRSA infections. In addition to common clinical syndromes, the...
